PH19533A - Teichomycin a2 pure single factors 1,2,3,4 and 5,their pharmaceutical composition and method for their production - Google Patents

Teichomycin a2 pure single factors 1,2,3,4 and 5,their pharmaceutical composition and method for their production

Info

Publication number
PH19533A
PH19533A PH28999A PH28999A PH19533A PH 19533 A PH19533 A PH 19533A PH 28999 A PH28999 A PH 28999A PH 28999 A PH28999 A PH 28999A PH 19533 A PH19533 A PH 19533A
Authority
PH
Philippines
Prior art keywords
teichomycin
production
pharmaceutical composition
pure single
single factors
Prior art date
Application number
PH28999A
Other languages
English (en)
Inventor
Angelo Borghi
Rosa Pallanza
Carolina Coronelli
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of PH19533A publication Critical patent/PH19533A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH28999A 1982-06-08 1983-06-01 Teichomycin a2 pure single factors 1,2,3,4 and 5,their pharmaceutical composition and method for their production PH19533A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (1)

Publication Number Publication Date
PH19533A true PH19533A (en) 1986-05-20

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28999A PH19533A (en) 1982-06-08 1983-06-01 Teichomycin a2 pure single factors 1,2,3,4 and 5,their pharmaceutical composition and method for their production

Country Status (32)

Country Link
US (1) US4542018A (no)
JP (5) JPS591423A (no)
KR (1) KR900008246B1 (no)
AU (1) AU560966B2 (no)
BE (1) BE896993A (no)
BG (1) BG60529B2 (no)
CA (1) CA1208204A (no)
CH (1) CH657139A5 (no)
DE (1) DE3320342A1 (no)
DK (1) DK159117C (no)
ES (2) ES8503689A1 (no)
FI (1) FI73697C (no)
FR (1) FR2528050B1 (no)
GB (1) GB2121401B (no)
GR (1) GR78267B (no)
HK (1) HK55887A (no)
HU (1) HU193538B (no)
IE (1) IE55025B1 (no)
IL (1) IL68819A0 (no)
IT (1) IT1212085B (no)
LU (1) LU84853A1 (no)
MY (1) MY8700002A (no)
NL (1) NL8301980A (no)
NO (1) NO159104C (no)
NZ (1) NZ204480A (no)
PH (1) PH19533A (no)
PT (1) PT76831B (no)
SE (1) SE459094B (no)
SG (1) SG70686G (no)
SU (1) SU1318170A3 (no)
UA (1) UA6025A1 (no)
ZA (1) ZA833607B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
HUT63860A (en) * 1990-12-05 1993-10-28 Lepetit Spa Process for producing 39-decarboxy-38-(hydroxymethyl) derivatives of teikoplanin antibiotics
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
CA2250578C (en) 1996-04-23 2003-06-24 Versicor Inc. Improved chemical process for preparing amide derivatives of antibiotic a 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20050090433A1 (en) * 2002-11-18 2005-04-28 Vicuron Pharmaceuticals, Inc Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
NL8301980A (nl) 1984-01-02
LU84853A1 (fr) 1984-03-07
JPS591423A (ja) 1984-01-06
SE8303211D0 (sv) 1983-06-07
SE459094B (sv) 1989-06-05
GB2121401B (en) 1985-09-18
AU560966B2 (en) 1987-04-30
HU193538B (en) 1987-10-28
PT76831A (en) 1983-07-01
IT8321432A0 (it) 1983-06-02
FR2528050A1 (fr) 1983-12-09
ES522941A0 (es) 1985-04-01
ES8503689A1 (es) 1985-04-01
JPH0517237B2 (no) 1993-03-08
JPH0517236B2 (no) 1993-03-08
BE896993A (fr) 1983-12-07
DK245883A (da) 1983-12-09
SE8303211L (sv) 1983-12-09
KR840005170A (ko) 1984-11-05
US4542018A (en) 1985-09-17
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
JPH0224278B2 (no) 1990-05-29
HK55887A (en) 1987-08-07
ES536770A0 (es) 1985-08-16
GB8315003D0 (en) 1983-07-06
SG70686G (en) 1987-07-03
ES8506748A1 (es) 1985-08-16
PT76831B (en) 1986-04-09
DK159117B (da) 1990-09-03
IL68819A0 (en) 1983-09-30
SU1318170A3 (ru) 1987-06-15
NO831754L (no) 1983-12-09
NZ204480A (en) 1986-04-11
JPH0415238B2 (no) 1992-03-17
JPH02288887A (ja) 1990-11-28
DE3320342A1 (de) 1983-12-08
DK159117C (da) 1991-02-11
FI831660L (fi) 1983-12-09
MY8700002A (en) 1987-12-31
IE831329L (en) 1983-12-08
KR900008246B1 (ko) 1990-11-06
FI73697B (fi) 1987-07-31
GR78267B (no) 1984-09-26
CH657139A5 (fr) 1986-08-15
FR2528050B1 (fr) 1987-03-20
DE3320342C2 (no) 1991-07-11
CA1208204A (en) 1986-07-22
NO159104B (no) 1988-08-22
GB2121401A (en) 1983-12-21
DK245883D0 (da) 1983-05-31
JPH02288888A (ja) 1990-11-28
BG60529B2 (bg) 1995-07-28
UA6025A1 (uk) 1994-12-29
AU1496883A (en) 1983-12-15
JPH02291278A (ja) 1990-12-03
FI73697C (fi) 1987-11-09
FI831660A0 (fi) 1983-05-12
JPH02291279A (ja) 1990-12-03
ZA833607B (en) 1984-03-28
JPH0415237B2 (no) 1992-03-17
NO159104C (no) 1988-11-30

Similar Documents

Publication Publication Date Title
PH19533A (en) Teichomycin a2 pure single factors 1,2,3,4 and 5,their pharmaceutical composition and method for their production
DE3364288D1 (en) Boehmites and extremely pure pseudoboehmites, and process for their manufacture
HUT36116A (en) Process for producing n,n-piperazinyl- derivatives and pharmaceutical compositions containing them
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
IL67085A (en) Tetrapeptides,a process for manufacturing them and pharmaceutical compositions containing them
IL69985A0 (en) Lymphocyte growth factor,its production and pharmaceutical compositions containing it
HUT46303A (en) Process for producing 3-/omega-/3,5-di-/tetrabutil/-4-hydroxy-phenyl/-alkanoyl/-pyrroles andtheyr deoxy-analogues and pharmaceutical compositions containing them
IL72219A0 (en) Peptides,their production and pharmaceutical compositions containing them
IL68680A (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2-analogues,process for their preparation and pharmaceutical compositions containing them
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
DE3567638D1 (en) 2,4-dichloro-3-alkyl-6-nitrophenols and process for their preparation
DE3369994D1 (en) Benzothiopyrano(4,3,2,-cd)indazoles, their pharmaceutical compositions and methods for their production
HUT41984A (en) Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GR80730B (en) 1,2-dithiolan derivatives, processes for their production, pharmaceutical compositions containing them and their use
HUT35638A (en) Process for producing new 16-fluoro-16,17-didehydro-prostaglandines and pharmaceutical compositions containing them
CY1431A (en) 3,3-dialkyl-and,3,3-alkylene-indoline derivatives,processes for their production and pharmaceutical compositions,comprising them
DE3160364D1 (en) 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol, a process for producing same and a pharmaceutical composition
HUT40427A (en) Process for producing 1,3,4-oxa- and -thia-diazol derivatives and pharmaceutical compositions containing them
DE3574381D1 (en) Xanthinylmethylthiazolidines, process for their preparation and pharmaceutical compositions containing them
JPS5740498A (en) Novel 8 alpha-estra-1,3,5(10)-triene derivative, manufacture and drug composition
DE3360070D1 (en) 1,10-substituted 10-amino-deca-3,7-diene-nitriles and method for their preparation
DE3268558D1 (en) Pure 6,6-diiodopenicillanic acid and process for its preparation
AU542280B2 (en) Process for pharmaceutical 4(5)-acetyl-2-methyl-imidazole
DE3360730D1 (en) 1,10-substituted 1,11-diamino-undeca-3,7 dienes and process for their preparation
ZA83429B (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives,processes for their production and pharmaceutical compositions comprising them